Baader Bank Aktiengesellschaft’s Quest Diagnostics DGX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,331	Closed	-$444K	–	490
2025 Q3	$444K	Buy	2,331 +108	+5%	+$19.2K	0.03%	307
2025 Q2	$399K	Buy	2,223 +783	+54%	+$136K	0.03%	301
2025 Q1	$243K	Buy	1,440 +12	+0.8%	+$1.97K	0.02%	321
2024 Q4	$215K	Sell	1,428 -41	-3%	-$6.38K	0.01%	334
2024 Q3	$226K	Buy	+1,469	New	+$219K	0.01%	355
2023 Q2	–	Sell	-5,296	Closed	-$747K	–	439
2023 Q1	$747K	Buy	5,296 +83	+2%	+$11.9K	0.04%	198
2022 Q4	$816K	Hold	5,213	–	–	0.04%	202
2022 Q3	$640K	Hold	5,213	–	–	0.04%	232
2022 Q2	$693K	Hold	5,213	–	–	0.05%	227
2022 Q1	$713K	Hold	5,213	–	–	0.06%	167
2021 Q4	$902K	Buy	+5,213	New	+$793K	0.07%	161

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baader Bank Aktiengesellschaft's DGX Position: Q4 2025 in Review

Baader Bank Aktiengesellschaft sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 2,331 shares — an estimated $444K sold.

Baader Bank Aktiengesellschaft first reported a position in DGX in Q4 2021 and held it in 11 quarters. The position peaked at $902K in Q4 2021. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

Baader Bank Aktiengesellschaft reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 2,331 Quest Diagnostics shares in Q4 2025, an estimated $444K.
Baader Bank Aktiengesellschaft first reported a position in Quest Diagnostics in Q4 2021 and held it in 11 quarters.
Baader Bank Aktiengesellschaft's Quest Diagnostics position peaked at $902K in Q4 2021.
1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2025, filed 5 Feb 2026.